The Effect of Visualized Meditation on Anxiety, Pain, and Comfort in Patients Undergoing Colonoscopy
1 other identifier
interventional
72
1 country
1
Brief Summary
Colonoscopy is one of the most frequently performed procedures for the early diagnosis and treatment of intestinal diseases and plays a crucial role in the diagnosis and treatment of lower gastrointestinal disorders. However, for many patients, colonoscopy is considered an invasive, highly painful, and extremely uncomfortable procedure. Furthermore, the anxiety and fear felt before the procedure can affect patients in many ways. These negative feelings can disrupt patient comfort and cause the pain to become even more severe.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 4, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 27, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 28, 2025
CompletedFirst Submitted
Initial submission to the registry
November 15, 2025
CompletedFirst Posted
Study publicly available on registry
December 1, 2025
CompletedDecember 5, 2025
November 1, 2025
8 months
November 15, 2025
November 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
VAS Pain and Comfort Scale
This scale was developed by Price and colleagues (1983). It is used to measure subjective pain and comfort levels. The scale is represented by a 10-cm line representing the lowest and highest pain scores (0: no pain/discomfort, 10: most intolerable pain/discomfort).
From enrollment to the end of treatment at 4 months
The State Trait Anxiety Inventory (STAI)
The State Trait Anxiety Inventory (STAI), developed by Spielberger et al. in 1964, will be used to measure anxiety in this study. The scale has two dimensions: the STAI-S, which measures state anxiety, and the STAI-T, which measures trait anxiety. The STAI-S and STAI-T each consist of 20 items. Items 1-40 on the scale measure anxiety in four ways. The lowest score for both dimensions of the scale is 20, and the highest score is 80. As the score increases, the level of anxiety also increases.
From enrollment to the end of treatment at 4 months
Study Arms (2)
Visualized meditation group
ACTIVE COMPARATORIn the study, the experimental group will listen to visualized meditation sessions daily, morning and evening, for three days before the colonoscopy. On the morning of the colonoscopy, patients will be administered a personal information form, STAI1-2, pain scale, and comfort scale. After the procedure, the patients will be taken to the recovery area and will be administered the STAI1-2, pain scale, and comfort scale again.
Control group
NO INTERVENTIONIn the study, the control group will be administered a personal information form, STAI1-2, pain scale, and comfort scale on the morning of the colonoscopy. After the procedure, the patients will be taken to the recovery area and the STAI1-2, pain scale, and comfort scale will be administered again. The control group will receive standard clinical care procedures.
Interventions
In the study, the experimental group will listen to visualized meditation sessions daily, morning and evening, for three days before the colonoscopy. On the morning of the colonoscopy, patients will be administered a personal information form, STAI1-2, pain scale, and comfort scale. After the procedure, the patients will be taken to the recovery area and will be administered the STAI1-2, pain scale, and comfort scale again.
Eligibility Criteria
You may qualify if:
- Patients over the age of 18, with no hearing impairment,
- Submitting a colonoscopy for the first time,
- Not diagnosed with a psychiatric disorder and therefore not taking medication,
- Willing to participate in the study
You may not qualify if:
- Patients who refused to participate in the study, underwent a colonoscopy for biopsy, or underwent deep sedation.
- Patients who volunteered to participate and then wished to withdraw from the study at any stage.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gaziantep University
Gaziantep, Şehitkamil, 27310, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant Dr
Study Record Dates
First Submitted
November 15, 2025
First Posted
December 1, 2025
Study Start
March 4, 2025
Primary Completion
October 27, 2025
Study Completion
October 28, 2025
Last Updated
December 5, 2025
Record last verified: 2025-11
Data Sharing
- IPD Sharing
- Will not share
There is not a plan to make IPD available.